| Literature DB >> 28392887 |
Chencheng Feng1, Minghui Yang1, Minghong Lan1, Chang Liu1, Yang Zhang1, Bo Huang1, Huan Liu1, Yue Zhou1.
Abstract
Excessive reactive oxygen species (ROS) generation in degenerative intervertebral disc (IVD) indicates the contribution of oxidative stress to IVD degeneration (IDD), giving a novel insight into the pathogenesis of IDD. ROS are crucial intermediators in the signaling network of disc cells. They regulate the matrix metabolism, proinflammatory phenotype, apoptosis, autophagy, and senescence of disc cells. Oxidative stress not only reinforces matrix degradation and inflammation, but also promotes the decrease in the number of viable and functional cells in the microenvironment of IVDs. Moreover, ROS modify matrix proteins in IVDs to cause oxidative damage of disc extracellular matrix, impairing the mechanical function of IVDs. Consequently, the progression of IDD is accelerated. Therefore, a therapeutic strategy targeting oxidative stress would provide a novel perspective for IDD treatment. Various antioxidants have been proposed as effective drugs for IDD treatment. Antioxidant supplementation suppresses ROS production in disc cells to promote the matrix synthesis of disc cells and to prevent disc cells from death and senescence in vitro. However, there is not enough in vivo evidence to support the efficiency of antioxidant supplementation to retard the process of IDD. Further investigations based on in vivo and clinical studies will be required to develop effective antioxidative therapies for IDD.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28392887 PMCID: PMC5368368 DOI: 10.1155/2017/5601593
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1The redox homeostasis of intervertebral disc (IVD) cells. The role of the mitochondrion in reactive oxygen species (ROS) generation of disc cells has been well established. During the transportation of electrons, a small proportion of electrons (1%–3%) leak to produce ROS. However, the nonmitochondrial ROS generation through nicotinamide adenine dinucleotide phosphate (NADPH) oxidase or xanthine oxidase in disc cells remains unknown. Thus, “?” is labeled in these pathways. ROS scavenging is performed by antioxidants and detoxicating enzymes.
Reactive oxygen species (ROS) sensitive signaling proteins in disc cells.
| ROS sensitive signaling molecules | Experimental models | Cellular processes regulated by the molecules | Reference |
|---|---|---|---|
| ERK, JNK, and p38 | Rat AF cells (in vitro) | Matrix metabolism | [ |
| ERK, JNK, p38, Akt, p65 Nrf2, ATM, Chk2, and p53 | Human NP cells (in vitro) | Cell cycle progression | [ |
| p65 | Human NP cells (in vitro) | Proinflammatory phenotype | [ |
| JNK and p38 | Bovine NP cells (in vitro) | Matrix catabolic phenotype | [ |
| ERK | Rat NP cells (in vitro) | Autophagy | [ |
AF: annulus fibrosus; NP: nucleus pulposus.
Figure 2Disturbed redox homeostasis in the microenvironment of degenerative IVDs. Excessive reactive oxygen species (ROS) production and impaired antioxidative system exist in degenerative discs.
Figure 3The involvement of reactive oxygen species (ROS)/oxidative stress in the pathogenesis of intervertebral disc (IVD) degeneration (IDD). ROS activate various signaling pathways in IVD cells and consequently regulate the phenotype, apoptosis, autophagy, and senescence of disc cells. Sustained oxidative stress induced by ROS overproduction reinforces matrix degradation and inflammation and enhances the decrease in the number of viable and functional disc cells in IVDs. Furthermore, ROS alter the extracellular matrix (ECM) structure of IVDs through oxidative modification, impairing the mechanical function of IVDs. As a result, the progression of IDD is accelerated. SASP: senescence-associated secretory phenotype.
Therapeutic effects of antioxidants on degenerative disc cells and intervertebral disc degeneration.
| Antioxidant | Model (administration route) | Therapeutic effects | Reference |
|---|---|---|---|
| NAC | Rat AF cells (in vitro supplementation) | Suppressing catabolic and proinflammatory phenotype induced by H2O2 | [ |
| Rat discs (oral administration) | Delaying IDD process induced by disc puncture | [ | |
| Human NP cells (in vitro supplementation) | Retarding premature senescence induced by H2O2 | [ | |
| Rabbit AF cells (in vitro supplementation) | Restraining apoptosis induced by local anesthetics | [ | |
| Rat NP cells (in vitro supplementation) | Suppressing excessive autophagy induced by serum deprivation | [ | |
| Rat NP cells (in vitro supplementation) | Suppressing excessive autophagy induced by compression | [ | |
|
| |||
| Resveratrol | Human NP cells (in vitro supplementation) | Suppressing apoptosis | [ |
| Bovine NP cells (in vitro supplementation) | Inhibiting matrix catabolic phenotype and promoting matrix anabolism | [ | |
| Mouse discs (oral administration) | Delaying IDD process induced by disc puncture | [ | |
| Human NP cells (in vitro supplementation) | Inhibiting matrix catabolic phenotype and promoting matrix anabolism | [ | |
| Rat NP cells (in vitro supplementation) | Inhibiting apoptosis induced by IL-1 | [ | |
| Human NP cells (in vitro supplementation) | Suppressing matrix catabolic phenotype induced by TNF- | [ | |
| Human NP cells (in vitro supplementation) | Suppressing proinflammatory phenotype induced by IL-1 | [ | |
|
| |||
| EGCG | Human NP cells (in vitro supplementation) | Retarding premature senescence induced by H2O2 | [ |
| Human NP cells (in vitro supplementation) | Suppressing the proinflammatory and catabolic phenotype induced IL-1 | [ | |
|
| |||
| Fullerol | Human NP cells (in vitro supplementation) | Retarding matrix catabolism induced by H2O2 | [ |
| Rabbit discs (intradiscal injection) | Delaying IDD process induced by disc puncture | ||
|
| |||
| Cordycepin | Rat NP cells (in vitro supplementation) | Suppressing matrix catabolic phenotype induced by LPS | [ |
| Rat organ cultured discs (ex vivo supplementation) | Delaying IDD process induced by LPS | ||
|
| |||
| BMP7 | Human NP cells (in vitro supplementation) | Suppressing apoptosis and matrix catabolic phenotype induced by H2O2 | [ |
| IGF1 | Human AF cells (in vitro supplementation) | Retarding premature senescence induced by H2O2 | [ |
| HGF | Rabbit NP cells (in vitro supplementation) | Suppressing apoptosis and matrix catabolic and proinflammatory phenotype induced by H2O2 | [ |
| PQQ | Rat NP cells (in vitro supplementation) | Suppressing apoptosis and matrix catabolic phenotype induced by H2O2 | [ |
| Ferulic acid | Rabbit NP cells (in vitro supplementation) | Restraining apoptosis and matrix catabolic phenotype by H2O2 | [ |
| GSH | Human NP cells (in vitro supplementation) | Suppressing apoptosis and matrix catabolic phenotype induced by H2O2 | [ |
NP: nucleus pulposus; AF: annulus fibrosus; GSH: glutathione; NAC: N-acetylcysteine; IDD: intervertebral disc degeneration; IL: interleukin; TNF: tumor necrosis factor; EGCG: epigallocatechin 3-gallate; PQQ: pyrroloquinoline quinone; LPS: lipopolysaccharide; BMP: bone morphogenetic protein; IGF: insulin-like growth factor; HGF: hepatocyte growth factor.